Medpace Holdings, Inc. (MEDP)

Every figure this model derived for MEDP, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 45,974,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 502,688,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 1,050,285,000 AssetsCurrent 2026-06-30
current liabilities 1,435,429,000 LiabilitiesCurrent 2026-06-30
equity 433,861,000 StockholdersEquity 2026-06-30
interest expense 0 InterestPaidNet 2025-12-31
ocf 752,660,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 2,782,288,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 21,209,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up MEDP on one particular measure came for.

RatioValue
cash operating margin22.7
current ratio1.98
current ratio reported0.73
deferred revenue growth11.86
dilution pct-7.77
ebit cagr23.53
ebit yoy22.18
fcf margin25.4
growth cv0.28
operating margin20.97
owner earnings margin24.64
revenue growth24.67
revenue growth per share35.17
rpo growth0.0
rule of 4045.63
sbc pct revenue0.76

What to be careful about

What this model itself distrusts about MEDP's figures. Written by the derivation as it ran, not added afterwards.